Editorial: Obesity and cancer: update on etiology, molecular biomarkers and biotargets, clinical strategies, and epidemiology

Authors

Eva Surmacz, Allysta Pharmaceuticals, Inc., Belmont, WA, United States.
Valentina Guarnotta, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, Section of Endocrinology, University of Palermo, Palermo, Italy.
Michaela Ruth Reagan, Center for Molecular Medicine, MaineHealth Institute of Research (MHIR), Scarborough, ME, United States.

Document Type

Editorial

Publication Date

8-14-2023

Institution/Department

Center for Molecular Medicine, MaineHealth Institute for Research

Journal Title

Frontiers in endocrinology

MeSH Headings

Humans; Causality; Neoplasms (etiology, genetics); Obesity (epidemiology)

ISSN

1664-2392

First Page

1258994

Recommended Citation

Surmacz E, Guarnotta V, Reagan MR. Editorial: Obesity and cancer: update on etiology, molecular biomarkers and biotargets, clinical strategies, and epidemiology. Front Endocrinol (Lausanne). 2023;14:1258994. Published 2023 Aug 14. doi:10.3389/fendo.2023.1258994